Loading clinical trials...
Loading clinical trials...
Convalescent Methylene Blue Treated (MBT) Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients: a Randomized Double Blind Study (COnV-ert)
Conditions
Interventions
Convalescent anti-SARS-CoV-2 MBT plasma
Control Group
Locations
4
Spain
Germans Trias i Pujol Hospital
Badalona, Barcelona, Spain
Hospital Sant Bernabé (Hospital de Berga)
Berga, Barcelona, Spain
CUAP Manresa (Planta 0 del CAP Bages)
Manresa, Barcelona, Spain
Hospital Universitari de Bellvitge
Barcelona, Spain
Start Date
November 10, 2020
Primary Completion Date
May 31, 2021
Completion Date
July 28, 2021
Last Updated
September 8, 2021
NCT06631287
NCT05141058
NCT06679140
NCT06160128
NCT07300839
NCT05566483
Lead Sponsor
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions